A peek behind the paper: drug repurposing for improved cancer therapy in TP53 mutant tumors
In this interview we take a peek behind the paper with Corresponding Author, Joanna Zawacka-Pankau, and learn more about her work using a drug repurposing approach to improve cancer therapies and possibly overcome drug resistance.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>